• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与快速进展性间质性肺病相关的皮肌炎的危险因素及预测模型

Risk Factors and Predictive Model for Dermatomyositis Associated with Rapidly Progressive Interstitial Lung Disease.

作者信息

Wang Kai, Tian Yian, Liu Shanshan, Zhang Zhongyuan, Shen Leilei, Meng Deqian, Li Ju

机构信息

Department of Rheumatology, the Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huaian, 223001, People's Republic of China.

出版信息

Pharmgenomics Pers Med. 2022 Sep 1;15:775-783. doi: 10.2147/PGPM.S369556. eCollection 2022.

DOI:10.2147/PGPM.S369556
PMID:36071824
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9444234/
Abstract

BACKGROUND

Rapidly progressive interstitial lung disease (RP-ILD) is a significant complication that determines the prognosis of dermatomyositis (DM). Early RP-ILD diagnosis can improve screening and diagnostic efficiency and provide meaningful guidance to carry out early and aggressive treatment.

METHODS

A retrospective screening of 284 patients with DM was performed. Clinical and laboratory characteristics of the patients were recorded. The risk factors of RP-ILD in DM patients were screened by logistic regression (LR) and machine learning methods, and the prediction models of RP-ILD were developed by machine learning methods, namely least absolute shrinkage and selection operator (LASSO), random forest (RF), and extreme gradient boosting (XGBoost).

RESULTS

According to the result of univariate LR, disease duration is a protective factor for RP-ILD, and ESR, CRP, anti-Ro-52 antibody and anti-MDA5 antibody are risk factors for RP-ILD. The top 10 important variables of the 3 machine learning models were intersected to obtain common important variables, and there were 5 common important variables, namely disease duration, LDH, CRP, anti-Ro-52 antibody and anti-MDA5 antibody. The AUC of LASSO, RF and XGBoost test set were 0.661, 0.667 and 0.867, respectively. We further validated the performance of these three models on validation set, and the results showed that, the AUC of LASSO, RF and XGBoost were 0.764, 0.727 and 0.909, respectively. Based on the results of the models, XGBoost is the optimal model in this study.

CONCLUSION

Disease duration, LDH, CRP, anti-Ro-52 antibody and anti-MDA5 antibody are vital risk factors for RP-ILD in DM. The prediction model constructed using XGBoost can be used for risk identification and early intervention in DM patients with RP-ILD and practical application.

摘要

背景

快速进展性间质性肺病(RP-ILD)是决定皮肌炎(DM)预后的重要并发症。早期诊断RP-ILD可提高筛查和诊断效率,并为开展早期积极治疗提供有意义的指导。

方法

对284例DM患者进行回顾性筛查。记录患者的临床和实验室特征。采用逻辑回归(LR)和机器学习方法筛选DM患者发生RP-ILD的危险因素,并通过机器学习方法即最小绝对收缩和选择算子(LASSO)、随机森林(RF)和极端梯度提升(XGBoost)建立RP-ILD的预测模型。

结果

单因素LR结果显示,病程是RP-ILD的保护因素,而血沉、C反应蛋白、抗Ro-52抗体和抗MDA5抗体是RP-ILD的危险因素。对3种机器学习模型的前10个重要变量进行交集运算,得到5个共同的重要变量,即病程、乳酸脱氢酶、C反应蛋白、抗Ro-52抗体和抗MDA5抗体。LASSO、RF和XGBoost测试集的AUC分别为0.661、0.667和0.867。我们在验证集上进一步验证了这3种模型的性能,结果显示,LASSO、RF和XGBoost的AUC分别为0.764、0.727和0.909。基于模型结果,XGBoost是本研究中的最优模型。

结论

病程、乳酸脱氢酶、C反应蛋白、抗Ro-52抗体和抗MDA5抗体是DM患者发生RP-ILD的重要危险因素。利用XGBoost构建的预测模型可用于DM合并RP-ILD患者的风险识别和早期干预及实际应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7861/9444234/f92d7f00814c/PGPM-15-775-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7861/9444234/8982c2f604d9/PGPM-15-775-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7861/9444234/f92d7f00814c/PGPM-15-775-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7861/9444234/8982c2f604d9/PGPM-15-775-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7861/9444234/f92d7f00814c/PGPM-15-775-g0002.jpg

相似文献

1
Risk Factors and Predictive Model for Dermatomyositis Associated with Rapidly Progressive Interstitial Lung Disease.与快速进展性间质性肺病相关的皮肌炎的危险因素及预测模型
Pharmgenomics Pers Med. 2022 Sep 1;15:775-783. doi: 10.2147/PGPM.S369556. eCollection 2022.
2
Predictors of rapidly progressive interstitial lung disease and prognosis in Chinese patients with anti-melanoma differentiation-associated gene 5-positive dermatomyositis.抗黑色素瘤分化相关基因 5 阳性皮肌炎中国患者快速进展性间质性肺病的预测因素及预后。
Front Immunol. 2023 Aug 24;14:1209282. doi: 10.3389/fimmu.2023.1209282. eCollection 2023.
3
Different Multivariable Risk Factors for Rapid Progressive Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis and Anti-Synthetase Syndrome.抗MDA5阳性皮肌炎和抗合成酶综合征中快速进展性间质性肺病的不同多变量危险因素。
Front Immunol. 2022 Mar 7;13:845988. doi: 10.3389/fimmu.2022.845988. eCollection 2022.
4
A nomogram based on clinical factors and CT radiomics for predicting anti-MDA5+ DM complicated by RP-ILD.基于临床因素和 CT 放射组学的列线图预测抗 MDA5+DM 合并 RP-ILD。
Rheumatology (Oxford). 2024 Mar 1;63(3):809-816. doi: 10.1093/rheumatology/kead263.
5
Prediction model for the pretreatment evaluation of mortality risk in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with interstitial lung disease.抗黑色素瘤分化相关基因 5 抗体阳性皮肌炎伴间质性肺病患者死亡风险的预处理评估预测模型。
Front Immunol. 2022 Sep 23;13:978708. doi: 10.3389/fimmu.2022.978708. eCollection 2022.
6
A Clinical Risk Model to Predict Rapidly Progressive Interstitial Lung Disease Incidence in Dermatomyositis.一种预测皮肌炎中快速进展性间质性肺病发病率的临床风险模型。
Front Med (Lausanne). 2021 Sep 27;8:733599. doi: 10.3389/fmed.2021.733599. eCollection 2021.
7
Risk Prediction for Rapidly Progressive Interstitial Lung Disease in Anti-MDA5-Positive Dermatomyositis: The CRAFT Model.抗 MDA5 阳性皮肌炎快速进展性间质性肺病的风险预测:CRAFT 模型。
Med Sci Monit. 2023 Jun 15;29:e940251. doi: 10.12659/MSM.940251.
8
[Value of serum YKL-40 in the diagnosis of anti-MDA5-positive patients with dermatomyositis complicated with severe pulmonary injury].血清YKL-40在抗MDA5阳性皮肌炎合并严重肺损伤患者诊断中的价值
Beijing Da Xue Xue Bao Yi Xue Ban. 2021 Dec 18;53(6):1055-1060. doi: 10.19723/j.issn.1671-167X.2021.06.008.
9
Predictors of Poor Outcome of Anti-MDA5-Associated Rapidly Progressive Interstitial Lung Disease in a Chinese Cohort with Dermatomyositis.抗 MDA5 相关快速进展性间质性肺疾病在中国皮肌炎队列中的不良预后预测因素。
J Immunol Res. 2020 Nov 25;2020:2024869. doi: 10.1155/2020/2024869. eCollection 2020.
10
Clinical characteristics of dermatomyositis patients with isolated anti-Ro-52 antibody associated rapid progressive interstitial lung disease: Data from the largest single Chinese center.抗 Ro-52 抗体相关皮肌炎患者孤立性快速进展性间质性肺病的临床特征:来自最大单中心中国人群的数据。
Respir Med. 2019 Aug;155:127-132. doi: 10.1016/j.rmed.2019.07.020. Epub 2019 Jul 20.

引用本文的文献

1
Associated factors in the development of rapidly progressive interstitial lung disease in patients with idiopathic inflammatory myopathies: a systematic review and meta-analysis.特发性炎性肌病患者快速进展性间质性肺病发生的相关因素:一项系统评价和荟萃分析
Front Immunol. 2025 Aug 5;16:1628928. doi: 10.3389/fimmu.2025.1628928. eCollection 2025.
2
The clinical features and mortality predictors for idiopathic inflammatory myopathies: a retrospective study of 572 patients and the "AIRMT" Score.特发性炎性肌病的临床特征及死亡预测因素:一项对572例患者的回顾性研究及“AIRMT”评分
Clin Rheumatol. 2025 Jul 2. doi: 10.1007/s10067-025-07495-9.
3

本文引用的文献

1
Pharmacologic Treatment of Anti-MDA5 Rapidly Progressive Interstitial Lung Disease.抗MDA5快速进展性间质性肺疾病的药物治疗
Curr Treatm Opt Rheumatol. 2021;7(4):319-333. doi: 10.1007/s40674-021-00186-x. Epub 2021 Sep 28.
2
Successful Treatment of Anti-MDA5 Antibody-Positive Dermatomyositis-Associated Rapidly Progressive-Interstitial Lung Disease by Plasma Exchange: Two Case Reports.血浆置换成功治疗抗MDA5抗体阳性皮肌炎相关快速进展性间质性肺病:两例报告
Clin Med Insights Case Rep. 2021 Jul 27;14:11795476211036322. doi: 10.1177/11795476211036322. eCollection 2021.
3
Dermatomyositis.
Predictive Biomarkers and Novel Treatments for the Progressive Fibrosing Phenotype in Interstitial Lung Disease Associated with Connective Tissue Disease.
与结缔组织病相关的间质性肺病中进行性纤维化表型的预测生物标志物和新疗法
Biomedicines. 2025 Jun 13;13(6):1463. doi: 10.3390/biomedicines13061463.
4
Determinants for worsening in systemic autoimmune rheumatic disease-associated interstitial lung disease: a systematic review and meta-analysis of cohort studies.系统性自身免疫性风湿疾病相关间质性肺疾病病情恶化的决定因素:队列研究的系统评价与荟萃分析
Front Med (Lausanne). 2024 Nov 27;11:1465753. doi: 10.3389/fmed.2024.1465753. eCollection 2024.
5
Prognostic significance of natural killer cell depletion in predicting progressive fibrosing interstitial lung disease in idiopathic inflammatory myopathies.自然杀伤细胞耗竭对特发性炎症性肌病进行性纤维性间质性肺病的预测意义。
Front Immunol. 2024 Apr 30;15:1404828. doi: 10.3389/fimmu.2024.1404828. eCollection 2024.
6
Association of anti-Ro52 autoantibody with interstitial lung disease in autoimmune diseases: a systematic review and meta-analysis.抗 Ro52 自身抗体与自身免疫性疾病中间质性肺病的相关性:系统评价和荟萃分析。
BMJ Open Respir Res. 2023 Nov 29;10(1):e002076. doi: 10.1136/bmjresp-2023-002076.
7
Mortality risk in patients with anti-MDA5 dermatomyositis is related to rapidly progressive interstitial lung disease and anti-Ro52 antibody.抗 MDA5 皮肌炎患者的死亡率与快速进展性间质性肺病和抗 Ro52 抗体有关。
Arthritis Res Ther. 2023 Jul 24;25(1):127. doi: 10.1186/s13075-023-03100-z.
8
Risk Prediction for Rapidly Progressive Interstitial Lung Disease in Anti-MDA5-Positive Dermatomyositis: The CRAFT Model.抗 MDA5 阳性皮肌炎快速进展性间质性肺病的风险预测:CRAFT 模型。
Med Sci Monit. 2023 Jun 15;29:e940251. doi: 10.12659/MSM.940251.
9
A Machine Learning Framework Based on Extreme Gradient Boosting to Predict the Occurrence and Development of Infectious Diseases in Laying Hen Farms, Taking H9N2 as an Example.以H9N2为例,基于极端梯度提升的机器学习框架预测蛋鸡养殖场传染病的发生与发展
Animals (Basel). 2023 Apr 27;13(9):1494. doi: 10.3390/ani13091494.
N Engl J Med. 2021 Jun 24;384(25):2437. doi: 10.1056/NEJMicm2033425.
4
Myositis specific antibodies are associated with isolated anti-Ro-52 associated interstitial lung disease.肌炎特异性抗体与孤立性抗 Ro-52 相关的间质性肺疾病相关。
Rheumatology (Oxford). 2022 Mar 2;61(3):1083-1091. doi: 10.1093/rheumatology/keab488.
5
Tocilizumab for refractory rapidly progressive interstitial lung disease related to anti-MDA5-positive dermatomyositis.托珠单抗治疗与抗MDA5阳性皮肌炎相关的难治性快速进展性间质性肺病。
Rheumatology (Oxford). 2021 Jul 1;60(7):e227-e228. doi: 10.1093/rheumatology/keaa906.
6
Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis.抗 MDA5 阳性皮肌炎中的间质性肺病。
Clin Rev Allergy Immunol. 2021 Apr;60(2):293-304. doi: 10.1007/s12016-020-08822-5. Epub 2021 Jan 6.
7
Elevated carcinoembryonic antigen predicts rapidly progressive interstitial lung disease in clinically amyopathic dermatomyositis.癌胚抗原升高预示着临床无肌病性皮肌炎的快速进展性间质性肺病。
Rheumatology (Oxford). 2021 Aug 2;60(8):3896-3903. doi: 10.1093/rheumatology/keaa819.
8
Prognostic values of anti-Ro52 antibodies in anti-MDA5-positive clinically amyopathic dermatomyositis associated with interstitial lung disease.抗 MDA5 阳性伴间质性肺病的无肌病性皮肌炎中抗 Ro52 抗体的预后价值。
Rheumatology (Oxford). 2021 Jul 1;60(7):3343-3351. doi: 10.1093/rheumatology/keaa786.
9
Increased Levels of Soluble CD206 Associated with Rapidly Progressive Interstitial Lung Disease in Patients with Dermatomyositis.可溶性 CD206 水平升高与皮肌炎患者快速进展性间质性肺病相关。
Mediators Inflamm. 2020 Oct 26;2020:7948095. doi: 10.1155/2020/7948095. eCollection 2020.
10
Anti-Ro52 antibody is an independent risk factor for interstitial lung disease in dermatomyositis.抗 Ro52 抗体是皮肌炎并发间质性肺病的独立危险因素。
Respir Med. 2020 Oct;172:106134. doi: 10.1016/j.rmed.2020.106134. Epub 2020 Sep 1.